PGNX
Progenics Pharmaceuticals Inc
PGNX
PGNX
Delisted
PGNX was delisted on the 19th of June, 2020.
76 hedge funds and large institutions have $219M invested in Progenics Pharmaceuticals Inc in 2014 Q2 according to their latest regulatory filings, with 9 funds opening new positions, 28 increasing their positions, 25 reducing their positions, and 20 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more capital invested
Capital invested by funds: $ → $
less funds holding
Funds holding: →
55% less first-time investments, than exits
New positions opened: 9 | Existing positions closed: 20
Holders
76
Holding in Top 10
1
Calls
$948K
Puts
$781K
Top Buyers
| 1 | +$4.53M | |
| 2 | +$886K | |
| 3 | +$570K | |
| 4 |
JG
Jefferies Group
New York
|
+$560K |
| 5 |
PFC
Phocas Financial Corp
Alameda,
California
|
+$544K |
Top Sellers
| 1 | -$3.21M | |
| 2 | -$2.6M | |
| 3 | -$1.65M | |
| 4 |
Fidelity Investments
Boston,
Massachusetts
|
-$1.42M |
| 5 |
BFA
BlackRock Fund Advisors
San Francisco,
California
|
-$718K |